Erika V.

Erika V. has a wealth of experience in the pharmaceutical industry. Erika began their career in 2002 as a Senior Scientist II at UCB Research. In 2004, they joined ArQule as a Senior Investigator and Lead Investigator. In 2008, they were promoted to Associate Director, Analytical Discovery and Pharmaceutical Development, where they established a multifunctional analytical and bio-physical laboratory. In 2014, they moved to ArQule's wholly-owned subsidiary, Merck@Co., as Head of CMC. In 2020, they were promoted to Executive Director at Merck and, in 2021, they joined Cardurion Pharmaceuticals as Vice President, Manufacturing and CMC and CMC Consultant.

Erika V. completed their Ph.D. in Chemistry from Kent State University between 1996 and 2002. Erika also attended Univerzita Komenského v Bratislave between 1990 and 1995, where they studied School of Pharmacy.